Mark D. Wilkie

Dr. Mark D. Wilkie


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2019 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
SJSimon P. Jochems
Simon P. Jochems
KRKarin de Ruiter
Karin de Ruiter
CSCarla Solórzano
Carla Solórzano
AVAstrid Voskamp
Astrid Voskamp
EMElena Mitsi
Elena Mitsi
DFDaniela M. Ferreira
Daniela M. Ferreira
Streptococcus pneumoniae (Spn) is a common cause of respiratory infection, but also frequently colonizes the nasopharynx in the absence of disease. We used mass cytometry to study immune cells from nasal biopsy samples collected following experimental human pneumococcal challenge in order to identify immunological mechanisms of control of Spn colonization. Using 37 markers, we characterized 293 nasal immune cell clusters, of which 7 were associated with Spn colonization. B cell and CD161+CD8+ T cell clusters were significantly lower in colonized than in noncolonized subjects. By following a second cohort before and after pneumococcal challenge we observed that B cells were depleted from the nasal mucosa upon Spn colonization. This associated with an expansion of Spn polysaccharide–specific and total plasmablasts in blood. Moreover, increased responses of blood mucosa-associated invariant T (MAIT) cells against in vitro stimulation with pneumococcus prior to challenge associated with protection against establishment of Spn colonization and with increased mucosal MAIT cell populations. These results implicate MAIT cells in the protection against pneumococcal colonization and demonstrate that colonization affects mucosal and circulating B cell populations.

30 July 2018 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
MWMark D. Wilkie
Mark D. Wilkie
HFHelen M. Fraser
Helen M. Fraser
HRHemal Raja
Hemal Raja

19 February 2019 in Clinical Otolaryngology
Verified
Journal Article
Closed access
PDF file
MWMark D. Wilkie
Mark D. Wilkie
SDSujata De
Sujata De
MKMadhankumar Krishnan
Madhankumar Krishnan

18 November 2019 in The Journal of Laryngology & Otology
Verified
Journal Article
Closed access
PDF file
MWMark D. Wilkie
Mark D. Wilkie
DCD Chudek
D Chudek
CWC J Webb
C J Webb
APA Panarese
A Panarese
GBG Banhegyi
G Banhegyi
Objective: This study sought to compare disease recidivism rates between canal wall up mastoidectomy and a canal wall down with obliteration technique.Methods: Patients undergoing primary cholesteatoma surgery at our institution over a five-year period (2013–2017) using the aforementioned techniques were eligible for inclusion in the study. Rates of discharge and disease recidivism were analysed using chi-square statistics.Results: A total of 104 ears (98 patients) were included. The mean follow-up period was 30 months (range, 12–52 months). A canal wall down with mastoid obliteration technique was performed in 55 cases and a canal wall up approach was performed in 49 cases. Disease recidivism rates were 7.3 per cent and 16.3 per cent in the canal wall down with mastoid obliteration and canal wall up groups respectively (p = 0.02), whilst discharge rates were similar (7.3 per cent and 10.2 per cent respectively).Conclusion: Our direct comparative data suggest that canal wall down mastoidectomy with obliteration is superior to a canal wall up technique in primary cholesteatoma surgery, providing a lower recidivism rate combined with a low post-operative ear discharge rate.

1 March 2013 in Journal of Infection
Verified
Journal Article
Closed access
MWMark D. Wilkie
Mark D. Wilkie
MHM.F. Hanson
M.F. Hanson
PSP.F. Statham
P.F. Statham
PBP.M. Brennan
P.M. Brennan

30 March 2014 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
MWMark D. Wilkie
Mark D. Wilkie
KLKathryn A. Lightbody
Kathryn A. Lightbody
DLDaniel Lythgoe
Daniel Lythgoe
STSankalap Tandon
Sankalap Tandon
JLJeffrey Lancaster
Jeffrey Lancaster
TJTerrence M. Jones
Terrence M. Jones